. Author manuscript; available in PMC: 2016 Jan 31.

Published in final edited form as: AJNR Am J Neuroradiol. 2014 Sep 25;36(2):259–264. doi: 10.3174/ajnr.A4103

Table 3.

Differences of clinical and imaging thresholds in patients receiving thrombolysis versus untreated patients.

	No reperfusion therapy	IV- and/or IA-therapy	P-value
*DWI*

Area under the curve (AUC) ±SE for predicting poor outcome	0.935±0.06	0.724±0.05	0.011
90% specificity for poor outcome (prognostic yield), mL	>19.7(42.3%)	>51.8(19.5%)	0.016^*
95% specificity for poor outcome (prognostic yield), mL	>20.5(40.5%)	> 74.8(16.1%)	0.007^*
100% specificity for poor outcome (prognostic yield), mL	>30.6(35.1%)	> 103.1(10.4%)	0.003^*

*NIHSSS*

Area under the curve (AUC) ±SE for predicting poor outcome	0.903±0.06	0.827±0.04	0.314
90% specificity for poor outcome (prognostic yield)	>12(37.8%)	> 16(23.0%)	0.142^*
95% specificity for poor outcome (prognostic yield)	>15(27.0%)	>19(14.9%)	0.182^*
100% specificity for poor outcome (prognostic yield)	>17(16.2%)	>20(9.2%)	0.414^*

P-value for comparison between prognostic yields is stated.